Actual Medicinal Product (AMP) Sastravi 125mg/31.25mg/200mg tablets (Accord-UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from all strenghts of Stanek tablets (Teva UK Ltd) and Stalevo tablets (Orion Pharma (UK) Ltd).

Generic
Levodopa + Carbidopa + Entacapone
Formulation
Levodopa 125mg / Carbidopa 31.25mg / Entacapone 200mg tablets
  • Levodopa + Carbidopa + Entacapone
    • Levodopa 125mg / Carbidopa 31.25mg / Entacapone 200mg tablets

      • Sastravi 125mg/31.25mg/200mg tablets (Accord-UK Ltd)